Photo taken from Pritam Singha Roy/Twitter
Sep 6, 2023, 18:29
Pritam Singha Roy: If high-dose methotrexate is unavoidable in curing osteosarcoma is an ever-lasting debate.
In a post by Pritam Singha Roy, Associate Consultant at , on Twitter:
“If high-dose methotrexate is unavoidable in curing osteosarcoma is an ever-lasting debate; especially pertinent in Lower Middle Income Countries, where methotrexate TDM may not be universally accessible. Join us on 14th September at 7 pm.”
Source: Pritam Singha Roy/Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22